Research will beat blood cancer

The Eastwood family knew it back in 1960, and so do we. That’s why we’ve invested over £500 million in world-class blood cancer research since 1960 – research which has changed the lives of blood cancer patients.

At any one time we have over £90 million invested in research. We’re currently funding over 1,000 researchers and clinicians across over 220 active research projects, as well as countless more awards to train the research leaders of the future.

Our research by blood cancer type

Since 1960, we’ve invested more than £500 million in research to save lives and improve the lives of people with leukaemialymphomamyeloma and other blood cancers.

At any one time we have over £90 million invested in research, and we’re currently funding over 1,000 researchers and clinicians across more than 220 active research projects, as well as numerous awards to train the research leaders of the future.

Leukaemia

Our researchers are making discoveries that will benefit patients with both chronic and acute forms of leukaemia.

Other blood cancers

Conditions like MPN, MDS and MGUS are a priority for our researchers because in some cases if we can treat them, we can prevent other blood cancers developing. We'll have more information on our work around MGUS and MDS soon.